News

Scientists identify potential drug candidates for deadly pediatric leukemia

Scientists at Sanford Burnham Prebys have shown that two existing drug candidates—JAK inhibitors and Mepron—hold potential as treatments for a deadly acute myeloid leukemia (AML) subtype that is more common in children.

Starving tumors by blocking glutamine uptake

Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified a drug candidate that blocks the uptake of glutamine, a key food source for many tumors, and slows the growth of melanoma.

Scientists shrink pancreatic tumors by starving their cellular “neighbors”

Scientists demonstrated for the first time that blocking “cell drinking,” or macropinocytosis, in the thick tissue surrounding a pancreatic tumor slowed tumor growth.

Leprosy drug holds promise as at-home treatment for COVID-19

Phase 2 clinical trial could begin immediately for clofazimine, an FDA-approved drug on WHO’s List of Essential Medicines.

Evan Snyder named Fellow of the American Institute for Medical and Biological Engineering

Renowned stem cell researcher recognized by his peers for seminal contributions to regenerative medicine.